Latest Market Research Report 2025

The global   molecular diagnostics market   was valued at USD 25.75 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 3.97% from 2025 to 2030. This growth is driven by several key factors, including technological advancements, an expanding elderly population, and the rising demand for accurate and efficient genetic testing solutions. In particular, the growing popularity of Point-of-Care (POC) testing is reshaping the diagnostic landscape, fueled by increased patient awareness and a demand for faster, more accessible healthcare solutions. The demand for rapid diagnostic results is encouraging innovation in portable and user-friendly testing platforms. One notable example is the development of a portable RT-PCR machine by Huwel Lifesciences in February 2023. This device is capable of detecting various viruses, including those causing respiratory diseases and sexually transmitted infections (STIs), in approximately 30 minutes. With accuracy comp...

  Molecular Diagnostics Industry Overview The global molecular diagnostics market size was valued at USD 37.04 billion in 2021 and is expected to decline at a compound annual growth rate (CAGR) of -1.6% from 2022 to 2030. The shrinking of the market can be attributed to the decline in demand for molecular COVID-19 testing during the forecast period. However, factors such as technological advancements, rising elderly population, and increasing demand for genetic testing is boosting the growth of the market. In addition, rising demand for PoC testing can be attributed to increasing demand for self-testing diagnostics, and patient awareness about faster diagnostics. The outbreak of COVID-19 impelled the diagnostics industry into action, with a race to develop novel and rapid diagnostics kits for the detection of coronavirus. The pandemic led to a spike in the revenue of companies operating in the infectious diseases segment. For instance, in April 2021, a 59% rise in revenue was re...